In a landmark decision on May 14, 2001, the United States Supreme Court unanimously ruled 8-0 against the use of marijuana for medical purposes, citing a strict interpretation of federal law. The case stemmed from a challenge presented by medical marijuana advocates and patients seeking relief from debilitating conditions. They claimed that the federal prohibition on marijuana violated their rights to use the drug for medical purposes, particularly for pain relief and other therapeutic benefits. The Court's ruling underscored the federal government’s authority over drug regulation, emphasizing that the Controlled Substances Act categorically prohibits the use and distribution of marijuana, regardless of state laws permitting its medical use. Justice Clarence Thomas, writing for the majority, stated that Congress had the right to regulate drugs, and this regulation included cannabis, which is classified as a Schedule I substance, indicating a high potential for abuse and no accepted medical use at the federal level. This decision intensified the ongoing debate surrounding marijuana, particularly as several states had begun to legalize its use for medicinal purposes. Proponents of medical marijuana decried the ruling, arguing that it denied patients critical therapeutic options and reflected outdated perceptions of cannabis. Conversely, opponents viewed the ruling as a necessary measure to uphold federal drug laws and prevent potential misuse. The Supreme Court’s decision posed significant implications for the medical marijuana movement, challenging states that had enacted their own laws to enable patient access. The ruling resonated nationally, serving as a reminder of the ongoing tension between state-level reforms and federal prohibition in the evolving landscape of drug policy in the United States. As discussions around cannabis reform continue, this pivotal ruling remains a touchstone in the debate over medical marijuana legalization.